Australia
HaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Multiple Myeloma Drug Candidate
* Lonza to manufacture drug substance for clinical supply of HaemaLogiX's lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility inGuangzhou (CN) * HaemaLogiX will leverage Lonza's regulatory expertise, global manufacturing footprint, and extensive experience in ...
GigaSpaces Announced as Winner in the 2021 Digital Transformation & Operational Excellence Awards
The provider of Digital Integration Hub (DIH) software solutions was recognized for the "Best Achievement in an Enterprise Architecture Program" Award for its work with leading European automaker Groupe PSA, supporting its efforts to reduce CO2 emissions NEW YORK, Jan. 27, 2022 /PRNewswire/ -- G...
Appendix 4C - Q2 FY22 Quarterly Cash Flow Report
Highlights: * NZ's regulator Medsafe authorizes Phase 2 clinical trial for ATH434; more jurisdictions to follow * New poster presentation and publications provide further evidence of potential of ATH434 to treat neurodegenerative diseases * New US composition of matter patent secures exclus...
OPEC Fund provides US$1.5bn in new development financing in 2021, deepens impact and fully utilizes COVID-19 facility
VIENNA, Jan. 27, 2022 /PRNewswire/ -- With a total of US$1.5 billion committed in 2021, the OPEC Fund for International Development made a strong contribution to the global development agenda last year. The OPEC Fund, which marks its 46th anniversary on 28 January, focused on helping its partner ...
Asia facing 'triple policy challenge' to long-term growth, new Asia House report finds
LONDON, Jan. 27, 2022 /PRNewswire/ -- Asia is facing a triple policy challenge that could see even the region's fastest-growing economies fall into the 'middle-income trap', according to new research byAsia House. The report highlights Asia's position at a crossroads, with countries' trajectorie...
Asia facing 'triple policy challenge' to long-term growth, new Asia House report finds
LONDON, Jan. 26, 2022 /PRNewswire/ -- Asia is facing a triple policy challenge that could see even the region's fastest-growing economies fall into the 'middle-income trap', according to new research byAsia House. The report highlights Asia's position at a crossroads, with countries' trajectorie...
Appian Process Mining Now Available
Appian takes customers from process discovery to workflow design and automation in one unified platform SYDNEY, Jan. 27, 2022 /PRNewswire/ -- Appian (NASDAQ: APPN) today announced the general availability ofAppian Process Mining, the easiest way to identify and address workflow bottlenecks. Now ...
CRRC Delivers Four Additional Second-Generation SDA1 Locomotives to SCT Logistics in Australia
MELBOURNE, Australia, Jan. 26, 2022 /PRNewswire/ -- CRRC Corporation Limited ("CRRC", 1766.HK) announced that four additional second-generation SDA1 Locomotives have shipped toAustralia in January, as part of the supply order between CRRC Ziyang, the subsidiary of CRRC, and SCT Logistics, a leadi...
Gefen International Announces Expansion of its Transactive Model
TEL-AVIV, Israel, Jan. 26, 2022 /PRNewswire/ -- Gefen International (ASX: GFN) announced the expansion of the model feature. The feature provides insurance companies the ability to divide their commissions between agents and sub-agents. Mid to large tier insurance companies, can now have permit a...
ChannelAdvisor Achieves New Milestone to Help Fuel Global E-Commerce Growth for Brands
Leading multichannel commerce platform now offers over 300 global marketplace and retailer integrations MELBOURNE, Australia, Jan. 26, 2022 /PRNewswire/ -- ChannelAdvisor Corporation (NYSE: ECOM), a leading provider of cloud-based e-commerce solutions that enable brands and retailers to increase...
KAZIA THERAPEUTICS TO PARTICIPATE IN EDISON GROUP'S GLOBAL HEALTHCARE 'OPEN HOUSE' VIRTUAL CONFERENCE
SYDNEY, Jan. 25, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that CEO, DrJames Garner, will be speaking at the Edison Group 'Open House' Event, to be held virtually from25-27 January 2022. Kazia ...
Amcor builds on sustainability progress with science-based targets and the commitment to reach net zero emissions by 2050
ZURICH, Jan. 25, 2022 /PRNewswire/ -- Amcor (NYSE: AMCR) (ASX:AMC), a global leader in developing and producing responsible packaging solutions, today announced a further increase in its sustainability efforts by committing to science-based targets to reduce greenhouse gas (GHG) emissions and to ...
Deliverect Raises $150 Million in Series D Funding, as it Reaches 100 Million Orders Processed
Company also announces launch of Deliverect App Store, building a dedicated
ecosystem for online order automation
NEW YORK and LONDON, Jan. 25, 2022 /PRNewswire/ -- Deliverect
IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly
SINGAPORE, Jan. 24, 2022 /PRNewswire/ -- Concept Medical Inc.,
Flying Car Certified to Fly! - Civil Aviation Authority issues AirCar the Certificate of Airworthiness
BRATISLAVA, Slovakia, Jan. 24, 2022 /PRNewswire/ -- AirCar
ECINS Launches Australia Community Support Program Awarding $500,000 (AUD) in Free Services & Subscriptions to Indigenous Organisations and Educational Institutions
>> ECINS Australia Offers Collaborative Case Management Software to Empower Indigenous Organisations & Educational Institutions to Streamline Processes in Order to Meet Exploding Demands DUNSBOROUGH, Australia, Jan. 21, 2022 /PRNewswire/ -- ECINS Australia, the global provider of multi-agency ca...
Hinova Announces First Patient Dosed in a Phase I Clinical Trial of HP518, an orally bioavailable Chimeric Degrader targeting Androgen Receptor for Prostate Cancer Treatment
MELBOURNE, Australia, Jan. 21, 2022 /PRNewswire/ -- Hinova Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on developing novel therapeutics for cancers and metabolic diseases through targeted protein degradation technologies, announced that the first patient with metastat...
Hinova Announces First Patient Dosed in a Phase I Clinical Trial of HP518, an Orally Bioavailable Chimeric Degrader Targeting Androgen Receptor for Prostate Cancer Treatment
MELBOURNE, Australia, Jan. 20, 2022 /PRNewswire/ -- Hinova Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on developing novel therapeutics for cancers and metabolic diseases through targeted protein degradation technologies, today announced that the first patient with m...
Infosys Recognized as Global Top Employer for the Second Consecutive Year; Ranked #1 in India Again
BENGALURU, India, Jan. 20, 2022 /PRNewswire/ -- Infosys
Aboriginal Male Healing Centre's Holistic Approach Breaks Cycle of Domestic Violence with Data-driven Case Management Solution Built in Western Australia
>> ECINS works with Centre to custom build new client engagement module to establish rehabilitation program for domestic violence offenders with long-term successful outcomes NEWMAN, Australia, Jan. 20, 2022 /PRNewswire/ -- The Aboriginal Male Healing Centre (AMHC), a not-for-profit organisation...
Week's Top Stories
Most Reposted
Hong Leong Bank Unveils HLB opus Extended Exclusively by Private Invitation
[Picked up by 317 media titles]
2026-09-03 23:53Agoda Named Official Travel Partner of Eurovision's Inaugural Asian Edition
[Picked up by 312 media titles]
2026-09-02 12:17Visa Launches Enhanced A2A Protect Innovations to Help Financial Institutions Stop Fraud Before Money Leaves Accounts
[Picked up by 311 media titles]
2026-09-02 08:30Klook Takes Creator Commerce Beyond Influence With Kreator Shops
[Picked up by 307 media titles]
2026-09-01 11:00DayOne and TNB Explore Up To 1.5 GW of On-Site Power Generation to Advance Malaysia's Energy Resilience and Digital Economy
[Picked up by 292 media titles]
2026-09-01 17:36